Abstract
Low-carbohydrate diets (LChD) have become very popular among the general population. These diets have been used to lose body weight and to ameliorate various abnormalities like diabetes, nonalcoholic fatty liver disease, polycystic ovary syndrome, narcolepsy, epilepsy, and others. Reports suggest that body weight reduction and glycemic control could be attained while following LChD. However, these advantages are more notably found in short periods of time consuming an LChD. Indeed, the safety and efficacy of the latter diets in the long term have not been sufficiently explored. In contrast to what has been proposed, other mentioned pathologies are not improved or are even worsened by carbohydrate restriction. Therefore, the aim of this review is to define the concept of LChD and to explain their clinical effects in the short and long term, their influence on metabolism, and the opinion of nutrition or health authorities. Finally, evincing the research gaps of LChD that are here exposed will later allow us to reach a consensus with regard to their utilization.
References
1.
World Health Organization: Preventing chronic diseases: a vital investment. WHO global report. 2005. http://www.who.int/chp/chronic_disease_report/contents/en/index.html.
2.
World Health Organization: Diet, nutrition and the prevention of chronic diseases. Joint WHO/FAO expert consultation. WHO Technical Report Series 916. Geneva, WHO, 2003.
3.
Nordmann AJ, Nordmann A, Briel M, et al: Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:285–293.
4.
Gardner CD, Kiazand A, Alhassan S, et al: Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study – a randomized trial. JAMA 2007;297:969–977.
5.
Dansinger ML, Gleason JA, Schaefer EJ: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005;293:43–54.
6.
Bravata DM, Sanders L, Huang J, et al: Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003;289:1837–1850.
7.
Eaton SB, Eaton SB 3rd: Paleolithic vs. modern diets-selected pathophysiological implications. Eur J Nutr 2000;39:67–70.
8.
Cordain L, Eaton SB, Sebastian A, et al: Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005;81:341–354.
9.
Cordain L, Eaton SB, Miller JB, et al: The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr 2002;56(suppl):42–52.
10.
Cordain L, Miller JB, Eaton SB, et al: Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets. Am J Clin Nutr 2000;71:682–692.
11.
Mercader J: Mozambican grass seed consumption during the Middle Stone Age. Science 2009;326:1680–1683.
12.
Kendall CW, Jenkins DJ: A dietary portfolio: maximal reduction of low-density lipoprotein cholesterol with diet. Curr Atheroscler Rep 2004;6:492–498.
13.
Keys A: Mediterranean diet and public health: personal reflections. Am J Clin Nutr 1995;61:S321–S323.
14.
Jenkins DJ, Kendall CW, Popovich DG, et al: Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism 2001;50:494–503.
15.
Trowell H, Painter N, Burkitt D: Aspects of the epidemiology of diverticular disease and ischemic heart disease. Am J Dig Dis 1974;19:864–873.
16.
Stock AL, Yudkin J: Nutrient intake of subject of low carbohydrate diet used in treatment of obesity. Am J Clin Nutr 1970;23:948–952.
17.
Adam-Perrot A, Clifton P, Brouns F: Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev 2006;7:49–58.
18.
Kerksick CM, Wismann-Bunn J, Fogt D, et al: Changes in weight loss, body composition and cardiovascular disease risk after altering macronutrient distributions during a regular exercise program in obese women. Nutr J 2010;22:9–59.
19.
Crowe TC: Safety of low-carbohydrate diets. Obes Rev 2005;6:235–245.
20.
Mahan LK, Escott-Stump S: Guidelines for dietary planning; in Mahan KL, Escott-Stump S: Krause’s Food and Nutrition Therapy, ed 12. Barcelona, Elsevier, 2009.
21.
Westman EC, Feinman RD, Mavropoulos JC, et al: Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007;86:276–284.
22.
Johnston CS, Tjonn SL, Swan PD, et al: Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 2006;83:1055–1061.
23.
Sumithran P, Proietto J: Ketogenic diets for weight loss: a review of their principles, safety and efficacy. Obes Res Clin Pract 2008;2:1–13.
24.
Lehninger AL, Nelson DL, Cox MM: Bioenergetics and metabolism; in Lehninger AL, Nelson DL, Cox MM: Principles of Biochemistry, ed 3. New York, Worth, 2005.
25.
DeVivo DC, Leckie MP, Ferrendelli JS, et al: Chronic ketosis and cerebral metabolism. Ann Neurol 1978;3:331–337.
26.
Ben-Avraham S, Harman-Boehm I, Schwarzfuchs D, et al: Dietary strategies for patients with type 2 diabetes in the era of multi-approaches: review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Res Clin Pract 2009;86 (suppl 1):S41–S48.
27.
Hession M, Rolland C, Kulkarni U, et al: Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009;10:36–50.
28.
Best TH, Franz DN, Gilbert DL, et al: Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54:2328–2330.
29.
De Koning L, Fung TT, Liao X, et al: Low-carbohydrate diet scores and risk of type 2 diabetes in men. Am J Clin Nutr 2011;93:844–850.
30.
Husain AM, Yancy WS Jr, Carwile ST, et al: Diet therapy for narcolepsy. Neurology 2004;62:2300–2302.
31.
Erlanson-Albertsson C, Mei J: The effect of low carbohydrate on energy metabolism. Int J Obes 2005;2:26–30.
32.
Acheson KJ, Blondel-Lubrano A, Oguey-Araymon S, et al: Protein choices targeting thermogenesis and metabolism. Am J Clin Nutr 2011;93:525–534.
33.
Kather H, Wieland E, Scheurer A, et al: Influences of variation in total energy intake and dietary composition on regulation of fat cell lipolysis in ideal-weight subjects. J Clin Invest 1987;80:566–572.
34.
Halyburton AK, Brinkworth GD, Wilson CJ, et al: Low-and high-carbohydrate weight-loss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr 2007;86:580–587.
35.
Veldhorst MA, Westerterp KR, van Vught AJ, et al: Presence or absence of carbohydrates and the proportion of fat in a high/protein diet affect appetite suppression but not energy expenditure in normal/weight human subjects fed in energy balance. Br J Nutr 2010;104:1395–1405.
36.
Buse JB, Polonsky KS, Burant CF: Type 2 Diabetes Mellitus; in Larsen PR, Kronenberg HM, Melmed S, et al (eds): Williams Textbook of Endocrinology, ed 10. Philadelphia, Saunders, 2003.
37.
Jenkins DJ, Wolever TM, Taylor RH, et al: Glycemic index foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362–366.
38.
Brand-Miller J, Hayne S, Petocz P, et al: Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003;26:2261–2267.
39.
Gannon MC, Nuttall FQ: Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 2004;53:2375–2382.
40.
Garg A, Bantle JP, Henry RR, et al: Effects of varying carbohydrate content of diet in patients with non-insulin dependent diabetes mellitus. JAMA 1994;271:1421–1428.
41.
Coulston AM, Hollenbeck CB, Swislocki AL, et al: Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care 1989;12:94–101.
42.
Garg A, Bonanome A, Grundy SM, et al: Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988;319:829–834.
43.
Halton TL, Willett WC, Liu S, et al: Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med 2006;355:1991–2002.
44.
Jebb SA, Lovegrove JA, Griffin BA: Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 2010;92:748–758.
45.
Wolever TM, Gibbs AL, Mehling C, et al: The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008;87:114–125.
46.
Shai I, Schwarzfuchs D, Henkin Y, et al: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229–241.
47.
Huttenlocher PR: Ketonemia and seizures: metabolic and anti-convulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536–540.
48.
Kossoff EH: The ketogenic diet: it’s about ‘time’. Dev Med Child Neurol 2009;51:252–253.
49.
Joshi CN, Greeenberg CR, Mhanni AA, Salman MS: Ketogenic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol 2009;40:314–316.
50.
Vining EP: Long-term health consequences of epilepsy diet treatments. Epilepsia 2008;49:27–29.
51.
Ríos VG: Complications of treatment of epilepsy by a ketogenic diet. Rev Neurol 2001;33:909–915.
52.
Kraft BD, Westman EC: Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutr Metab (Lond) 2009;6:10–13.
53.
Dashti HM, Mathew TC, Khadada M, et al: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007;302:249–256.
54.
Gill HK, Wu GY: Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets – are low carbohydrate diets the answer? World J Gastroenterol 2006;12:345–353.
55.
York LW, Puthalapattu S, Wu GY: Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 2009;29:365–379.
56.
Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106–1110.
57.
Tendler D, Lin S, Yancy WS Jr, et al: The effect of a low-carbohydrate ketogenic diet on non alcoholic fatty liver disease: a pilot study. Dig Dis Sci 2007;52:589–593.
58.
Haufe S, Engeli S, Kast P, et al: Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011;53:1504–1514.
59.
Solga FS, Alkhuraishe KC, Cope K, et al: Breath biomarkers and non-alcoholic fatty liver disease: prelimenary observations. Biomarkers 2006;11:174–183.
60.
Douglas CC, Gower BA, Darnell BE, et al: Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril 2006;85:679–688.
61.
O’Neil DF, Westman EC, Bernstein RK: The effects of a low-carbohydrate regimen on glycemic control and serum lipids in diabetes mellitus. Metab Syndr Relat Disord 2003;1:291–298.
62.
Lim SS, Clifton PM, Noakes M, et al: Obesity management in women with polycystic ovary syndrome. Womens Health (Lond Engl) 2007;3:72–86.
63.
Austin GL, Thiny MT, Westman EC, et al: A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci 2006;51:1307–1312.
64.
Mavropoulos JC, Yancy WS, Hepburn J, et al: The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond) 2005;2:35.
65.
Yancy WS Jr, Provenzale D, Westman EC: Improvement of gastroesophageal reflux disease after initiation of a low-carbohydrate diet: five brief case reports. Altern Ther Health Med 2001;7:116–119.
66.
Sacks FM, Bray GA, Carey VJ, et al: Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859–873.
67.
Foster GD, Wyatt HR, Hill JO, et al: Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010;153:147–157.
68.
Yancy WS Jr, Olsen MK, Guyton JR, et al: A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 2004;140:769–777.
69.
Foster GD, Wyatt HR, Hill JO, et al: A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082–2090.
70.
Samaha FF, Iqbal N, Seshadri P, et al: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074–2081.
71.
Stern L, Iqbal N, Seshadri P, et al: The effects of a low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 2004;140:778–785.
72.
Haimoto H, Sasakabe T, Wakai K, et al: Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes. Nutr Metab (Lond) 2009;6:6–21.
73.
Davis NJ, Tomuta N, Schechter C, et al: Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care 2009;32:1147–1152.
74.
Ma Y, Olendzki BC, Hafner AR, et al: Low-carbohydrate and high-fat intake among adult patients with poorly controlled type 2 diabetes mellitus. Nutrition 2006;22:1129–1136.
75.
Nielsen JV, Joensson EA: Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up. Nutr Metab (Lond) 2008;5:14.
76.
de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, et al: Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. Nutr Hosp 2010;25:730–735.
77.
Schwarz JM, Linfoot P, Dare D, et al: Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003;77:43–50.
78.
Browning JD, Bajer JA, Rogers T, et al: Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 2011;93:1048–1052.
79.
Moran LJ, Noakes M, Clifton PM, et al: Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:812–819.
80.
Neal EG, Chaffe H, Schwartz RH, et al: The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol 2008;7:500–506.
81.
Groesbeck DK, Bluml RM, Kossoff EH: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 2006;48:978–981.
82.
Bentourkia M, Tremblay S, Pifferi F, et al: PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis. Am J Physiol Endocrinol Metab 2009;296:E796–E801.
83.
Amiel SA, Archibald HR, Chusney G, et al: Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci (Lond) 1991;81:189–194.
84.
Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004;70:309–319.
85.
Malewiak MI, Griglio S, Le Liepvre X: Relationship between lipogenesis, ketogenesis, and malonyl-CoA content in isolated hepatocytes from the obese Zucker rat adapted to a high-fat diet. Metabolism 1985;34:604–611.
86.
Chearskul S, Delbridge E, Shulkes A: Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. Am J Clin Nutr 2008;87:1238–1246.
87.
Dreschfeld J: The Bradshawe Lecture on diabetic coma. Br Med J 1886;2:358–363.
88.
Barrena HC, Gazola VA, Furlan MM, et al: Ketogenesis evaluation in perfused liver of diabetic rats submitted to short-term insulin-induced hypoglycemia. Cell Biochem Funct 2009;26:383–387.
89.
Pelletier A, Tardif A, Gingras MH, et al: Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K. Mol Cell Biochem 2007;296:97–108.
90.
Yokoo H, Saitoh T, Shiraishi S, et al: Distinct effects of ketone bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells. J Pharmacol Exp Ther 2003;304:994–1002.
91.
Binimelis J, Webb SM, Serrano J, et al: Plasma immunoreactive somatostatin is elevated in diabetic ketoacidosis and correlates with plasma non-esterified fatty acid concentration. Diabet Med 1987;4:221–224.
92.
Beylot M: Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon. Diabetes Metab 1996;22:299–304.
93.
Finn PF, Dice JF: Proteolytic and lipolytic responses to starvation. Nutrition 2006;22:830–844.
94.
Bisschop PH, Pereira Arias AM, Ackermans MT, et al: The effects of carbohydrate variation in isocaloric diets on glycogenolysis and gluconeogenesis in healthy men. J Clin Endocrinol Metab 2000;85:1963–1967.
95.
Boden G: Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 2004;52:375–378.
96.
Haque M, Sanyal AJ: The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2002;16:709–731.
97.
Delarue J, Magnan C: Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007;10:142–148.
98.
Curtis JM, Grimsrud PA, Wright WS, et al: Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010;59:1132–1142.
99.
Tretter L, Adam-Vizi V: Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 2005;360:2335–2345.
100.
Vigouroux C, Caron-Debarle M, Le Dor C, et al: Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol 2011;43:862–876.
101.
Chinen I, Shimabukuro M, Yamakawa K, et al: Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 2007;148:160–165.
102.
Lin Y, Berg AH, Iyengar P, et al: The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005;280:4617–4626.
103.
Srinvasan S, Hatley ME, Bolick DT, et al: Hyperglycaemia-induced superoxide production decrease eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004;47:1727–1734.
104.
Sakai K, Matsumoto K, Nishikawa T, et al: Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Commun 2003;300:216–222.
105.
Ceriello A, Bortolotti N, Motz E, et al: Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 1999;48:1503–1508.
106.
Brehm BJ, Spang SE, Lattin BL, et al: The role of energy expenditure in the differential weight loss in obese women on low-fat and low-carbohydrate diets. J Clin Endocrinol Metab 2005;90:1475–1482.
107.
Brehm BJ, Seeley RJ, Daniels SR, et al: A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 2003;88:1617–1623.
108.
Shils ME: Modern Nutrition in Health and Disease, ed 9. Baltimore, Williams & Wilkins, 1999.
109.
Al-Khalifa A, Mathew TC, Al-Zaid NS, et al: Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition 2009;25:1177–1185.
110.
Karabatas LM, Lombardo YB, Basabe JC, et al: High-protein diet: effect on insulin secretion patterns from streptozotocin-diabetic rats and mice. Acta Physiol Pharmacol Ther Latinoam 1992;42:239–254.
111.
Dyson PA: A review of low and reduced carbohydrate diets and weight loss in type 2 diabetes. J Hum Nutr Diet 2008;21:530–538.
112.
Volek JS, Sharman MJ, Gómez AL, et al: Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women: J Am Coll Nutr 2004;23:177–184.
113.
Noble CA, Kushner RF: An update on low-carbohydrate, high-protein diets. Curr Opin Gastroenterol 2006;22:153–159.
114.
Foo SY, Heller ER, Wykrzykowska J, et al: Vascular effects of a low-carbohydrate high-protein diet. Proc Natl Acad Sci USA 2009;106:15418–15423.
115.
Bradley U, Spence M, Courtney CH, et al: Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk – a randomized control trial. Diabetes 2009;58:2741–2748.
116.
Johnston CS, Tjinn SL, Swann PD, et al: Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr 2006;83:1055–1061.
117.
Brinkworth GD, Noakes M, Clifton PM, et al: Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 2009;101:1493–1502.
118.
Russell WR, Gratz SW, Duncan SH, et al: High-protein, reduced-carbohydrate weight-loss diets promotes metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011;93:1062–1072.
119.
Kaneko T, Wang PY, Wang Y, et al: The long-term effect of low-carbohydrate/high-fat diet on the development of diabetes mellitus in spontaneously diabetic rats. Diabetes Metab 2000;26:459–464.
120.
Birkner E, Kasperczyk S, Kasperczyk A, et al: Metabolic and antioxidative changes in liver steatosis induced by high-fat, low-carbohydrate diet in rabbits. J Physiol Pharmacol 2005;56:45–58.
121.
Cardillo S, Seshadri P, Iqbal N: The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year follow-up of a randomized trial. Eur Rev Med Pharmacol Sci 2006;10:99–106.
122.
Haimoto H, Iwata M, Wakai K, et al: Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study. Diabetes Res Clin Pract 2008;79:350–356.
123.
Boiling CL, Westman EC, Yancy WS Jr: Carbohydrate-restricted diets for obesity and related diseases: an update. Curr Atheroscler Rep 2009;11:462–469.
124.
Larsen RN, Mann NJ, Maclean E, et al: The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomized controlled trial. Diabetologia 2011;54:731–740.
125.
Brinkworth GD, Noakes M, Buckley JD, et al: Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 months. Am J Clin Nutr 2009;90:23–32.
126.
Garg A, Grundy SM, Unger RH: Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes 1992;41:1278–1285.
127.
Backes AC, Abbasi F, Lamendola C, et al: Clinical experience with a relatively low carbohydrate, calorie-restricted diet improves insulin sensitivity and associated metabolic abnormalities in overweight, insulin resistant South Asian Indian women. Asia Pac J Clin Nutr 2008;17:669–671.
128.
Boden G, Sargrad K, Homkko C, et al: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005;142:403–411.
129.
Miyashita Y, Koide N, Othusuka M, et al: Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract 2004;65:235–241.
130.
Chen M, Bergman RN, Porte D Jr: Insulin resistance and beta-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988;67:951–957.
131.
McLaughlin T, Carter S, Lamendola C, et al: Effects of dietary macronutrient intake on insulin sensitivity and secretion and glucose and lipid metabolism in healthy, obese adolescents. J Clin Endocrinol Metab 2005;90:4496–4502.
132.
Allick G, Bisschop PH, Ackermans MT, et al: Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract 2004;65:235–241.
133.
Anderson JW: Effect of carbohydrate restriction and high carbohydrates diets on men with chemical diabetes. Am J Clin Nutr 1977;30:402:408.
134.
Gannon MC, Hoover H, Nuttal FQ: Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 weeks compared to 5 weeks in people with untreated type 2 diabetes. Nutr Metab (Lond) 2010;7:64–81.
135.
Kirk E, Reeds DN, Finck BN, et al: Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009;136:1552–1560.
136.
Muzio F, Mondazzi L, Harris W, et al: Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr 2007;86:946–951.
137.
Samaha FF, Iqbal N, Seshadri P, et al: A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074–2081.
138.
Sunehag AL, Toffolo G, Treuth MS, et al: Effects of dietary macronutrient content on glucose metabolism in children. J Clin Endocrinol Metab 2002;87:5168–5178.
139.
Sunehag AL, Toffolo G, Campioni M, et al: Effects of dietary macronutrient intake on insulin sensitivity and secretion and glucose and lipid metabolism in healthy, obese adolescents. J Clin Endocrinol Metab 2005;90:4496–4502.
140.
Yancy WS Jr, Foy M, Chalecki AM, et al: A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005;2:34.
141.
Westman EC, Yancy WS Jr, Mavropoulos JC, et al: The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 2008;5:36.
142.
Brinkworth GD, Buckley JD, Noakes M, et al: Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med 2009;169:1873–1880.
143.
Halyburton AK, Brinkworth GD, Wilson CJ, et al: Low- and high-carbohydrate weight-loss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr 2007;86:580–587.
144.
Fernstrom HM, Fernstrom JD: Brain tryptophan concentrations and serotonin synthesis remain responsive to food consumption after the ingestion of sequential meals. Am J Clin Nutr 1995;61:312–319.
145.
Fernstrom JD: Tryptophan, serotonin and carbohydrate appetite: will the real carbohydrate craver please stand up! J Nutr 1998;118:1417–1419.
146.
Leathwood PD: Tryptophan availability and serotonin synthesis. Proc Nutr Soc 1987;46:143–156.
147.
Ince BA, Anderson EJ, Neer RM: Lowering dietary protein to US recommended dietary allowance levels reduces urinary calcium excretion and bone resorption in young women. J Clin Endocrinol Metab 2004;89:3801–3807.
148.
Butki BD, Baumstark J, Driver S: Effects of a carbohydrate-restricted diet on affective responses to acute exercise among physically active participants. Percept Mot Skills 2003;96:607–615.
149.
Keith RE, O’Keeffe KA, Blessing DL, Wilson GD: Alterations in dietary carbohydrate, protein, and fat intake and mood state in trained female cyclists. Med Sci Sports Exerc 1991;23:212–216.
150.
Evans WJ, Hughes VA: Dietary carbohydrates and endurance exercise. Am J Clin Nutr 1985;41:1146–1154.
151.
Gardner CD, Kim S, Bersamin A, Dopler-Nelson M, et al: Micronutrient quality of weight-loss diets that focus on macronutrients: results from the A TO Z study. Am J Clin Nutr 2010;92:304–312.
152.
Bourges H, Casanueva E, Rosado J: Recomendaciones de Ingestión de Nutrimentos para la Población Mexicana: Base Fisiológica, ed 1. Mexico City, Editorial Panamericana, 2009, vol 1.
153.
Kerstetter JE, Allen LH: Dietary protein increases urinary calcium. J Nutr 1989;20:134–136.
154.
Crowe TC: Safety of low-carbohydrate diets. Obes Rev 2005;6:235–245.
155.
Green J, Kleeman CR: Role of bone in regulation of systemic acid-base balance. Kidney Int 1991;39:9–26.
156.
Wurtman RJ: Nutrients that modify brain function. Sci Am 2000;246:50–59.
157.
Chen YM, Ho SC, Woo JL: Greater fruit and vegetable intake is associated with increased bone mass among postmenopausal Chinese women. Br J Nutr 2006;96:745–751.
158.
New SA, Robins SP, Campbell MK, et al: Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr 2000;71:142–151.
159.
New SA, Bolton-Smith C, Grubb DA, et al: Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 1997;65:1831–1839.
160.
Kang MH, Kim MH, Bae YJ, et al: Vegetable and fruit intake and its relevance with serum osteocalcin and urinary deoxypyridinoline in Korean adults. Nutr Res Pract 2010;4:421–427.
161.
Stein K: High-protein, low-carbohydrate diets: do they work? J Am Diet Assoc 2000;100:760–761.
162.
Wycherley TP, Brinkworth GD, Keogh JB, et al: Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J Intern Med 2009;267:452–461.
163.
Grieb P, Kłapcińska B, Smol E, et al: Long-term consumption of a carbohydrate-restricted diet does not induce deleterious metabolic effects. Nutr Res 2008;28:825–833.
164.
Clifton PM, Keogh J: Metabolic effects of high-protein diets. Curr Atheroscler Rep 2007;9:472–478.
165.
Anderson JW, Konz EC, Jenkins DJ: Health advantages and disadvantages of weight-reducing diets: a computer analysis and critical review. J Am Coll Nutr 2000;19:578–590.
166.
Lagiou P, Sandin S, Weiderpass E, et al: Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Inter Med 2007;261:366–374.
167.
Trichopoulou A, Psaltopoulou T, Orfanos P, et al: Low-carbohydrate-high-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr 2007;61:575–581.
168.
American Heart Association: High-protein diets: AHA recommendation. 2003. http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/High-Protein-Diets_UCM_305989_Article.jsp.
169.
American Dietetic Association: Position of the American Dietetic Association: weight management. J Am Diet Assoc 2009;109:330–346.
170.
Bantle JP, Wylie-Rosett J, Albright AL, et al: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31:61–78.
171.
Kossoff EH, Pyzik PL, Furth SL, et al: Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002;43:1168–1171.
172.
Food Standards Agency: Starchy food. 2009. http://www.eatwell.gov.uk/healthydiet/nutritionessentials/starchfoods/.
173.
Heart and Stroke Foundation of Canada: Position statement: low carbohydrate diets and heart disease and stroke. 2004. http://www.heartandstroke.com/atf/cf/%7B99452D8B-E7F1-4BD6-A57D-B136CE6C95BF%7D/LowCarbDiets_PS(04)-English.pdf.
174.
US Department of Health and Human Services: Your guide to a healthy heart. 2005. http://www.nhlbi.nih.gov/health/public/heart/other/your_guide/healthyheart.pdf.
175.
Secretaría de Salud: México sano. 2008. http://portal.salud.gob.mx/descargas/pdf/period_mexsano/mexicosano_dic08.pdf.
176.
Secretaría de Salud: Norma Oficial Mexicana NOM-174-SSA1-1998, para el manejo integral de la obesidad. 1998. http://www.salud.gob.mx/unidades/cdi/nom/174ssa18.html.
177.
Secretaría de Salud: Norma Oficial Mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria. 1994. http://www.salud.gob.mx/unidades/cdi/nom/015ssa24.html.
178.
Wolever TM: Dietary carbohydrates and insulin action in humans. Br J Nutr 2000;83(suppl 1):97–102.
179.
Fuehrlein BS, Rutenberg MS, Silver JN, et al: Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets. J Clin Endocrinol Metab 2004;89:1641–1645.
180.
Sheard NF, Clark NG, Brand-Miller JC, et al: Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association. Diabetes Care 2004;27:2266–2271.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
